tirofiban and fibrin
tirofiban has been researched along with fibrin in 8 studies
Research
Studies (8)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (12.50) | 18.2507 |
| 2000's | 3 (37.50) | 29.6817 |
| 2010's | 3 (37.50) | 24.3611 |
| 2020's | 1 (12.50) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Atar, S; Birnbaum, Y; Luo, H; Nagai, T; Siegel, RJ | 1 |
| Hantgan, RR; Jerome, WG; Nagaswami, C; Stahle, MC; Weisel, JW | 1 |
| Chung, TW; Tsai, WJ; Yang, MC | 1 |
| Bittmann, I; Brandl, U; Brenner, P; Burdorf, L; Erhardt, M; Hammer, C; Jöckle, H; Michel, S; Mordstein, V; Reichart, B; Rössle, M; Schmoeckel, M; Thein, E | 1 |
| Heemskerk, JW; Lancé, MD; Lionikiene, AS; Mastenbroek, TG; Mutch, NJ; Swieringa, F; van der Meijden, PE; Whyte, CS | 1 |
| Barry, DM; Dai, XR; Fan, ML; Hou, SX; Jin, H; Kong, F; Lau, LF; Li, TT; Li, XY; Luo, SY; Zhang, GH; Zhou, LL | 1 |
| Gwon, S; Hwang, DW; Jeon, J; Kang, C; Kang, PM; Lee, D; Park, SC; Song, C | 1 |
| Jiang, P; Li, C; Lin, F; Qiao, C; Su, N; Sun, P; Yuan, X | 1 |
Other Studies
8 other study(ies) available for tirofiban and fibrin
| Article | Year |
|---|---|
Ultrasound has synergistic effects in vitro with tirofiban and heparin for thrombus dissolution.
Topics: Albumins; Blood Coagulation; Contrast Media; Fibrin; Fibrinolytic Agents; Fluorocarbons; Heparin; Humans; In Vitro Techniques; Sodium Chloride; Solubility; Sonication; Stents; Thrombosis; Time Factors; Tirofiban; Tissue Plasminogen Activator; Tyrosine | 1999 |
Tirofiban blocks platelet adhesion to fibrin with minimal perturbation of GpIIb/IIIa structure.
Topics: Adult; Circular Dichroism; Dose-Response Relationship, Drug; Fibrin; Humans; Microscopy, Electron; Nephelometry and Turbidimetry; Platelet Adhesiveness; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Protein Conformation; Protein Interaction Mapping; Protein Structure, Secondary; Protein Structure, Tertiary; Protein Subunits; Receptor Aggregation; Tirofiban; Tyrosine | 2002 |
A fibrin encapsulated liposomes-in-chitosan matrix (FLCM) for delivering water-soluble drugs. Influences of the surface properties of liposomes and the crosslinked fibrin network.
Topics: Amines; Chitosan; Cross-Linking Reagents; Delayed-Action Preparations; Drug Compounding; Fibrin; Glutaral; Liposomes; Organophosphates; Particle Size; Platelet Aggregation Inhibitors; Polyethylene Glycols; Porosity; Quinacrine; Solubility; Surface Properties; Time Factors; Tirofiban; Tyrosine; Water | 2006 |
Reduced fibrin deposition and intravascular thrombosis in hDAF transgenic pig hearts perfused with tirofiban.
Topics: Adult; Animals; Animals, Genetically Modified; Antibodies; CD55 Antigens; Complement C3; Complement C4; Creatine Kinase; Disaccharides; Fibrin; Fibrinolytic Agents; Heart; Heart Transplantation; Humans; Male; Myocardium; Swine; Thrombosis; Tirofiban; Transplantation, Heterologous; Tyrosine | 2007 |
Plasminogen associates with phosphatidylserine-exposing platelets and contributes to thrombus lysis under flow.
Topics: Blood Platelets; Crotalid Venoms; Fibrin; Fibrinolysin; Fibrinolysis; Fibrinolytic Agents; Flow Cytometry; Hemostatics; Hirudins; Lectins, C-Type; Microscopy, Confocal; Oligopeptides; Phosphatidylserines; Protein Binding; Rheology; Shear Strength; Thrombin; Thrombosis; Tirofiban; Tissue Plasminogen Activator; Tyrosine; Urokinase-Type Plasminogen Activator | 2015 |
A novel snake venom-derived GPIb antagonist, anfibatide, protects mice from acute experimental ischaemic stroke and reperfusion injury.
Topics: Animals; Bleeding Time; Blood Platelets; Brain Ischemia; Cell Count; Cerebral Hemorrhage; Crotalid Venoms; Dose-Response Relationship, Drug; Fibrin; Infarction, Middle Cerebral Artery; Lectins, C-Type; Male; Mice; Platelet Glycoprotein GPIb-IX Complex; Protective Agents; Reperfusion Injury; Stroke; Tirofiban; Tyrosine; von Willebrand Factor | 2015 |
Fibrin-Targeted and H
Topics: Animals; Boronic Acids; Carotid Artery Thrombosis; CD40 Ligand; Cell Survival; Chlorides; Drug Carriers; Drug Liberation; Endothelial Cells; Ferric Compounds; Fibrin; Fibrinolytic Agents; Fluorescent Dyes; Humans; Hydrogen Peroxide; Lipopeptides; Mice; Nanoparticles; Optical Imaging; Polymers; RAW 264.7 Cells; Theranostic Nanomedicine; Thrombosis; Tirofiban; Tumor Necrosis Factor-alpha | 2017 |
PLATELET SUPPRESSION BY TIROFIBAN AMELIORATES PULMONARY COAGULATION AND FIBRINOLYSIS ABNORMALITIES IN THE LUNGS OF MOUSE ANTIBODY-MEDIATED TRANSFUSION-RELATED ACUTE LUNG INJURY.
Topics: Acute Lung Injury; Antibodies; Fibrin; Fibrinolysis; Humans; Lung; Male; Platelet Aggregation Inhibitors; Tirofiban; Transfusion-Related Acute Lung Injury; Tyrosine | 2023 |